Murthy Simhambhatla launched his medtech career during the epic race to develop groundbreaking drug-eluting stent technologies as a new approach to battling cardiovascular disease. Over two decades later, following a career that took him across the globe and clinical specialities, Simhambhatla finds himself involved in another exciting push to bring new technologies to bear on prevalent medical problems. Simhambhatla leads Setpoint Medical, a trail blazer in the neurostimulation space that’s tapping the vagus nerve as way to battle inflammation. In this discussion, we’ll cover Simhambhatla’s career and how Setpoint is positioned for the future following a significant capital raise.


Chris Newmarker, executive editor of life sciences at MassDevice shares his Newmarker’s Newsmakers including Avonics, Invacare, Philips, Johnson & Johnson, 3M, Stryker, Edwards, Hologic, BD, Edwards, and Boston Scientific.

Thanks for listening to the DeviceTalks Weekly Podcast.

You can subscribe to the DeviceTalks Podcast Network on any major podcast player.

CEO Simhambhatla details how Setpoint Medical is poised to fulfill promise of bioelectronic medicine

In this episode, Boston Scientific Chair, CEO and President Mike Mahoney discusses his journey in the medical device industry, the qualities that make a great leader, and the strategies that have fueled the company's growth.
 
Inspired by his grandfather, a cardiac surgeon, Mahoney initially wanted to become a doctor but ended up pursuing a career in business. Mahoney saw an opportunity at Boston Scientific when the company was struggling. Despite the risks involved, he took on the role of CEO because he believed in his skills and had a long-term vision for the company.
 
Through the efforts of the company's leaders, a strong supply chain team, efficient operations, and a robust innovation pipeline, Boston Scientific has managed to maintain a 14% growth rate in a challenging market environment.
 
Mahoney also highlights the company's focus on interventional medicine, which allows for quick procedures and same-day patient discharges, reducing the burden on hospitals. Mahoney further discusses the company's urology division, which has grown from a $500 million business to a $2 billion business. This growth has been fueled by a combination of organic R&D and acquisitions, creating a wide portfolio of differentiated products. Mahoney further elaborates on the company's diverse portfolio, mentioning the success of their peripheral vascular business and the potential of their diagnostics portfolio.
 
Tune in to this episode for more on Mahoney’s strategies, challenges, and opportunities, offering valuable insights into the company's approach to driving growth and innovation in the medical device industry.

Thank you to Resonant Link for sponsoring this episode of Boston Scientific Talks. For more information about Resonant Link go to www.Resonant-Link.com.

Thank you for listening to the Boston Scientific Talks Podcast.

Subscribe to this podcast on every major podcast platform.

Boston Scientific CEO Mike Mahoney on leadership, growth, innovation, and career-changing gut checks

In this episode of Boston Scientific Talks, Sandra Nagale, PhD, Director of Digital Health Platforms and Products, breaks down the transformative role of AI within the medical device industry.
Motivated to drive impactful changes, Nagale emphasizes Boston Scientific's unwavering dedication to pioneering breakthrough medical solutions and enhancing patient and physician experiences through AI and emphasizes how products like BeatLogic and LUX-Dx ICM are redefining healthcare by providing actionable, real-time insights.

Navigating the complexities of melding AI with healthcare, Nagale accentuates the necessity for solutions rooted in evidence that genuinely amplifies value. She highlights the urgency to streamline patient experiences, mitigate healthcare worker challenges, and elevate the patient journey. As Boston Scientific spearheads these advancements, Nagale envisions a future where medical devices seamlessly integrate into holistic patient care – from early detection to treatment. Dive into this episode to uncover how Boston Scientific is steering the medtech industry into an AI-augmented future.

Thank you to S3 Connected Health for sponsoring this episode of Boston Scientific Talks. For more information about S3 Connected Health, go to s3connectedhealth.com.

Thank you for listening to the Boston Scientific Podcast.

Subscribe to this podcast on every major podcast platform.

Boston Scientific's Sandra Nagale predicts the future of medtech powered by AI innovations

A college introduction to biomechanics set Nitin Salunke on an expected path into the medical device industry. But once his course was set Salunke helped manage innovative product launches at several large medical device companies including WL Gore, Cordis and Covidien/Medtronic. But Salunke always had his eyes on leading a start-up. In this discussion you’ll learn how he used each opportunity to help achieve that dream. Today, he leads Supira Medical, a white-hot startup developing a new type of pVAD.  Salunke will also be a speaker at the upcoming DeviceTalks West meeting.

Thanks for listening to this episode of DeviceTalks Weekly.

Subscribe to the DeviceTalks Podcast Network on any major podcast channel.

How Nitin Salunke’s different mindset helped him shift career from engineer to CEO of Supira Medical

In the inaugural episode of Ortho Innovation Talks: Zimmer Biomet, Rachel Ellingson, SVP and Chief Strategy Officer at Zimmer Biomet, shares insights into the company's growth strategy, emphasizing that growth can be achieved not only through addition - like innovation and acquisition - but also through subtraction, such as exiting lower growth, non-core businesses. 

In the episode, Ellingson discusses the decision to spin off Zimmer Biomet's spine and dental businesses and the significant undertaking required to create a new public company, which required integrating and then disintegrating business segments, building corporate infrastructure, and establishing a dedicated leadership team for the new entity - a major initiative involving over 500 people and a dedicated separation management office.

Lastly, Ellingson discusses what's next in Zimmer Biomet's growth strategy, citing a balance between internal innovation and M&A and noting that the company plans to launch over 40 new products in the next 36 months, focusing on markets with at least 4% growth. 

Thank you to our season one sponsors, AcuityMD and Millstone Medical for supporting this podcast. To learn more about our episode sponsor, AcuityMD, please visit http://acuitymd.com.

Tune in and subscribe to DeviceTalks on all major podcast channels and follow youtube.com/@DeviceTalks to ensure you never miss an episode.

WATCH and LISTEN below, thank you for supporting Ortho Innovation Talks!

S1 Ep 1 - Zimmer Biomet's Rachel Ellingson on driving growth through portfolio shifts and M&A

In this episode, the DeviceTalks Editorial Team - Tom Salemi, Kayleen Brown - recaps the highlights of DeviceTalks Boston with MassDevice Editor in Chief Chris Newmarker, Holly Scott of the Mullings Group, and Paul Melnychuck, Vice President & General Manager, Advanced Components at Spectrum Plastics Group, A DuPont Business.

Spectrum Plastics Group sponsored the podcast. For more information go to SpectrumPlastics.com.

Please subscribe to the DeviceTalks Podcast Network.

Hear the Final Word About DeviceTalks Boston: Live Recording of DeviceTalks Weekly On Stage

In this episode of the DeviceTalks Weekly podcast, Kevin Chaplin, CEO of Kardium, a Vancouver-based electrophysiology device company, shares details of the company’s Globe® Pulsed Field Mapping and Ablation System. With $100 million in new capital, the company is poised to open a new front in the pulsed-field ablation battle.

Thank you to Freudenberg Medical for sponsoring this episode. Go to Freudenbergmedical.com for more information.

Thank you for listening to the DeviceTalks Weekly Podcast.

Subscribe now to the DeviceTalks Podcast Network so you don’t miss a future episode.

CEO Chaplin explains how Kardium packed the power of the globe into its PFA cardiac ablation device

In this episode of the DeviceTalks Weekly, Host Tom Salemi interviews Endiatx CEO Torrey Smith, who will be the closing keynote speaker at the DeviceTalks West conference on Oct. 16-17 at the Santa Clara Convention Center. Smith talks about his journey into MedTech. Why he quit his job. And where his dream of building a swallowable surgical robot can lead him and his company.

Register at West.DeviceTalks.com to see a demonstration of PillBot! Use the code DTPod25 to save 25%.

In this week’s Newmarker’s Newsmakers, MassDevice Editor Chris Newmarker highlights the top MedTech stories of the week from Boston Scientific, Medtronic, Synchron, Shockwave (now part of Johnson & Johnson Medtech) and Masimo.

Thanks for listening to the DeviceTalks Weekly Podcast.

Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.

DeviceTalks West Keynote Endiatx CEO Torrey Smith on why he launched one of MedTech’s Moonshots

In this episode of Neuro Innovation Talks, the newest podcast series in the DeviceTalks Podcast Network, the DeviceTalks editors invite Johnson & Johnson MedTech Neurovascular's Head of Global Marketing, John Murray to take over the podcast studio and bring to light the stories from the pioneering neurointerventionalists who have helped shape the stroke industry.

In the first episode, Host John Murray sits down with Alejandro Berenstein, MD, Professor of Neurosurgery, Pediatrics and Radiology, Director of pediatric Cerebrovascular Surgery, Mount Sinai Health System, to discuss the incredible evolution of neurovascular surgery and its impact on modern healthcare. Dr. Berenstein shares his early inspirations, key breakthroughs, and the significant role mentors played in shaping his illustrious career. Highlighting landmark projects like the pioneering treatments for Vein of Galen Malformations (VOGM) and facial vascular anomalies, Dr. Berenstein shares the complexities and triumphs of his work. His story provides a blueprint for aspiring medical professionals and innovators, demonstrating how personal experiences, visionary thinking, and collaborative efforts can lead to groundbreaking advancements that significantly impact patient outcomes.
Thank you to Zeus for sponsoring this episode of Neuro Innovation Talks. To learn more about how Zeus supports medical device companies, visit: www.zeusinc.com.

Special thanks to the following for their support in the development of this podcast: Joanna Colangelo, Johanna Fifi, Whitney Garrett, Howard Riina, Lillian Medina, and J. Mocco.

Tune in and subscribe to the DeviceTalks Podcast Network wherever you get your podcasts and follow youtube.com/@DeviceTalks to never miss an episode.

Thank you for supporting the Neuro Innovation Talks podcast!

J&J MedTech’s John Murray and Dr. Berenstein on the early evolution of neurovascular treatments

In this episode of AbbottTalks, Sandra Lesenfants, SVP of Abbott’s structural heart business, discusses the latest advancements in structural heart care, focusing on Abbott's transformative TriClip device for tricuspid regurgitation.

Lesenfants highlights Abbott’s commitment to patient-centered innovation, emphasizing the importance of creating solutions that meet patients’ needs through safe and effective technologies. She also shares Abbott’s approach to expanding access to minimally invasive therapies, particularly in underserved populations worldwide, and the role of physician partnerships in advancing structural heart interventions.

Lastly, Lesenfants underscores the company’s efforts to increase diversity in clinical trials, noting the importance of intentional inclusivity across gender and ethnicity to better serve diverse patient populations.

Thank you to Confluent Medical Technologies for sponsoring this episode of AbbottTalks. For more information on how Confluent Medical works with medical device companies, visit https://confluentmedical.com/.

Thank you for listening to the AbbottTalks Podcast. Tune in and subscribe to DeviceTalks on all major podcast channels to never miss an episode.

Abbott’s Lesenfants shares TriClip progress, patient-centered innovation & clinical trial diversity

In this episode of DeviceTalks Weekly, Host Tom Salemi interviews Kit Yee Au-Yeung, general manager of AQMed at SandBoxAQ, an Alphabet spinout using AI and sensors to develop new tools in several industries.

Sandbox’s medical group is using these new technologies to develop advanced AI-powered magnetocardiography (MCG) technology to improve cardiac diagnostics.

MassDevice’s Chris Newmarker also returns with his Newmarker’s Newsmakers including - Dr. Mehmet Oz, CMS, Supira, GE Healthcare and Medtronic. 

This episode is sponsored by DeviceTalks Boston.

Thank you for listening to this episode of the DeviceTalks Weekly Podcast.

Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.

How a love of science led SandboxAQ’s Kit Yee Au-Yeung to find better ways to monitor the heart

Where does Iman Jeddi see Intuitive’s da Vinci 5 - and robotics - fit into the future of surgery?

In this episode of IntuitiveTalks, Iman Jeddi, PhD, senior vice president and general manager of the company’s multi port platform, shares a vision for the future of surgery where robotic systems elevate the performance of surgeons and deliver greater care equity.

Jeddi’s career started in biomedical engineering, taking her through several start-ups and ultimately, Abbott. Her lifelong career goal to create technology that improved care for the many led her to join Intuitive Surgical in 2013.

Jeddi has held multiple leadership roles in engineering, operations, and quality. Prior to taking her current post, Jeddi was general manager of the single-port platform, da Vinci SP, so she brings a uniquely comprehensive perspective to the company’s surgical robotic portfolio.

The interview begins and ends with a personal story illustrating her belief in building medical devices and tools that can deliver better care for as many patients as possible.

Thank you to Aptyx for sponsoring this episode of IntuitiveTalks! Please visit www.aptyx.com to learn more about how Aptyx can help you manufacture your competitive edge.

Thank you for listening to the IntuitiveTalks Podcast.

Subscribe to this podcast on every major podcast platform.

Where Intuitive's Iman Jeddi sees da Vinci 5 - and robotics - fitting into the future of surgery

In this episode of DeviceTalks Weekly, we’ll hear how Perimeter Medical Imaging AI hopes to help surgeons get a clearer picture of whether they removed all cancerous tissue in a surgical procedure. CEO Adrian Mendes explains why 20% of patients who have undergone a lumpectomy must undergo a second operation to remove cancerous tissue that had been missed. Perimeter recently released the positive results from its pivotal study showing it more effectively addressed residual cancer at the surgical margin during surgery as compared to current standard methods. The company is planning to file a PMA with the FDA. Mendes also talks with Host Tom Salemi about his path from the technology industry into running an OCT and AI company targeting oncology.

Perimeter Medical Imaging AI sponsored this episode of the DeviceTalks Weekly Podcast. For more information go to https://perimetermed.com/

MedTech CEO Paul Grand joins Tom and MassDevice Editor Chris Newmarker for this week’s Newmarker’s Newsmakers - Capstan Medical, Cala Health, Anteris Technologies, MedTech M&A and top stories.

Thanks for listening to this episode of the DeviceTalks Weekly Podcast.

Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.

How Perimeter Medical hopes to use OCT & AI to boost surgeon confidence & patient peace of mind

In this episode of AbbottTalks, Kartik Sundareswaran, PhD, divisional VP, global clinical and regulatory affairs, Abbott Heart Failure, discusses Abbott’s pioneering work in heart failure care, focusing on technologies that improve outcomes and empower earlier interventions.

Sundareswaran’s path to MedTech began with a shift from computer engineering to biomedical research, where his early work studying blood flow patterns in children with congenital heart disease sparked a passion for solving cardiovascular challenges. This passion led him to roles at Thoratec, St. Jude Medical, and ultimately Abbott, where he has spent years advancing heart failure care.

The conversation highlights Abbott’s CardioMEMS™ Heart Failure System, a device enabling remote pulmonary artery pressure monitoring to reduce hospitalizations, and the HeartMate 3 LVAD, which provides life-extending support for patients with advanced heart failure. Sundareswaran also discusses the new TEAM-HF clinical trial, which combines CardioMEMS and HeartMate 3 to identify patients earlier and deliver timely, effective interventions.

This conversation comes to you courtesy of our episode sponsor, Tecan Group Ltd. To learn more about how Tecan works with medical device companies, visit: https://partnering.tecan.com/

Thank you for listening to the AbbottTalks Podcast. Tune in and subscribe to DeviceTalks on all major podcast channels to never miss an episode.

Abbott’s Sundareswaran envisions TEAM-HF & earlier interventions to redefine heart failure outcomes

In our final 2024 episode of the DeviceTalks Weekly podcast, ResMed CEO Mick Farrell shares the company’s strategy for reaching the billions of people who need help sleeping, breathing and remaining healthy. He talks with Host Tom Salemi about the company’s connectivity capabilities, response to wearable technology, and its take on a rival’s recall.

This episode is sponsored by Aptyx. Go to www.Aptyx.com to learn more.

We’ll also bring you the Newsmakers of 2024 brought to you by DeviceTalks Managing Editor Kayleen Brown as well as our Editorial Team - Editor Chris Newmarker, Senior Editor Danielle Kirsh, Associate Editor Sean Whooley, and Jim Hammerand, managing editor of Medical Design and Outsourcing.

Thank you for listening to this episode of the DeviceTalks Weekly Podcast.

Subscribe to the DeviceTalks Podcast Network on any major podcast player.

CEO Mick Farrell on how ResMed keeps on the leading edge of innovation; Our 2024’s Top Newsmakers

In this episode of the DeviceTalks Weekly podcast, Flow Medical CEO Jennifer Fried tells Host Tom Salemi the story of the MedTech startup that recently closed on a $5 million seed round. 

The story checks all the boxes of a great MedTech story. 

Physicians Dr. Jonathan Paul and Dr. Osman Ahmed crafted the idea of a new angiography, infusion, and monitoring catheter that could be used to dissolve pulmonary embolism. The napkin drawing grew into a company led by Fried, who had already exited her first startup. Now, with funds in hands, Flow Medical is moving into pre-clinical trials.

Before the interview, Salemi and DeviceTalks Managing Editor Kayleen Brown share news on the expanding DeviceTalks universe including new podcasts, new virtual discussions and a proven way for MedTech companies to tell their stories.

Thank you for listening to the DeviceTalks Weekly Podcast.

Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.

Flow Medical CEO Fried sees huge opportunity to clear pulmonary embolisms; State of DeviceTalks

In this episode of Neuro Innovation Talks, host John Murray interviews Charles "Chuck" Kerber, MD, Emeritus Professor of Radiology and Neurosurgery at UCSD, a pioneering force in neurovascular medicine, whose innovations—such as flow-directed catheters and cyanoacrylates for therapeutic embolization—transformed the field. Dr. Kerber reflects on his Appalachian roots and military experience, highlighting how these influences shaped his views on responsibility, mentorship, and patient-centered care. His philosophy of innovation, grounded in imagination and resilience, offers a blueprint for tackling complex medical challenges.

The discussion explores the iterative process of developing life-saving neurovascular devices, from early failures to groundbreaking successes, and emphasizes the vital role of collaboration with industry partners. Dr. Kerber shares stories of his mentorship style, which encouraged creativity and accountability, and its profound impact on the next generation of neurovascular physicians. He also underscores the importance of ethical considerations and humanity in patient care.

Looking ahead, Dr. Kerber advocates for the continued integration of creativity and teamwork in addressing future neurovascular challenges. He closes by offering young physicians advice on embracing imagination and perseverance to drive innovation and improve patient outcomes.

Thank you to Resonetics for sponsoring this episode of Structural Heart Talks. To learn more about how Resonetics supports medical device companies, visit: https://shorturl.at/E1wO8

Special thanks to the following for their support in the development of this podcast: Joanna Colangelo, Mark Dickinson, Whitney Garrett, Tracy Murray, SYK, Eytan Raz, MD, Boris Pabon, MD, Joseph Horton, MD, John Barr, MD, and special thanks to William Bank, MD.

Tune in and subscribe to the DeviceTalks Podcast Network wherever you get your podcasts and follow youtube.com/@DeviceTalks to never miss an episode.

Thank you for supporting the Neuro Innovation Talks podcast!

J&J's John Murray and Dr. Kerber on neurovascular innovation and lessons in imagination & resilience

In this episode of the DeviceTalks Weekly Podcast, we’ll play the interview Host Tom Salemi conducted with Adam Elsesser, CEO of Penumbra, which has grown into a force in the vascular and neurovascular industries.

Elsesser’s path into running a MedTech startup was quite accidental, but that unorthodox path has helped the company develop a unique culture for innovation. Elsesser shares that philosophy in this interview and explains why he prefers uncertainty over risk.

Kicking off the episode Jim Hammerand, managing editor of Medical Design and Outsourcing, visits with Chris Newmarker and Salemi to share the highlights of the magazine’s leadership issue including an in-depth interview he did with former Edwards Lifesciences CEO Mike Mussallem.

The three then run through this week’s Newmarker’s Newsmakers - Integra, Olympus, Johnson & Johnson, Boston Scientific, Stryker, and Inari.

Go to DeviceTalks.com to register for our conferences and digital events.

Thanks for listening to this episode of the DeviceTalks Weekly Podcast.

Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.

Why Penumbra CEO Adam Elsesser will take uncertainty over risk in MedTech innovation

In this episode of the DeviceTalks Weekly Podcast, we get an inside look into why Boston Scientific’s AF Solutions division has experienced such a meteoric rise over the past few years. CMO Dr. Brad Sutton lays out the problem facing patients and physicians when treating atrial fibrillation and how acquisitions of pulsed-field ablation tool FARAPULSE is changing the game.

This episode is sponsored by Freudenberg Medical. To discuss a partnership with Freudenberg Medical for your EP catheter portfolio, please visit https://ep.freudenbergmedical.com/.

Chris Newmarker of MassDevice joins Host Tom Salemi in delivering this week’s Newmarker’s Newsmakers - Abbott, Boston Scientific, Intuitive, and Medtronic.

Thank you for listening to the DeviceTalks Weekly Podcast.

Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.

Boston Scientific’s Brad Sutton explains why FARAPULSE may be part of the best story in MedTech

In this episode of the DeviceTalk Weekly podcast, Host Tom Salemi talks with MedTech legend Daniel Hawkins, a serial entrepreneur who has a hand in many industry success stories. He was employee number six at Intuitive before setting out on a path of innovation, developing the technologies around companies like Shockwave Medical.

More recently, Hawkins was CEO of Avail Medsystems, the presumed leader of the pack of companies trying to redefine OR communications, but that company shuttered last year when it couldn’t raise additional capital.

Today, Hawkins is leading Vista.ai, which is selling an AI-enabled package that makes it much easier for MRI technologists to capture meaningful images of the heart. Hawkins sees Vista.ai as improving patient care while also helping imaging centers address the crushing shortfall of experts.

This episode is sponsored by DeviceTalks Boston. Register to attend our April 30-May 1 event of the year at Boston.Devicetalks.com.

Thanks for listening to the DeviceTalks Weekly Podcast.

Subscribe to the DeviceTalks Podcast Network so you don’t miss out on a future episode.

Why proven MedTech inventor and CEO Daniel Hawkins sees a huge opportunity in AI-powered MRIs

In this episode of the DeviceTalks Weekly Podcast, Host Tom Salemi talks with Highridge CEO Rebecca Whitney and Executive Chairman Eric Major about the swirling spinal market. Whitney and Major share what makes the spine industry different from other MedTech sectors and why they believe Highridge is uniquely positioned to grab a large piece of the market.

The episode is sponsored by DeviceTalks Boston. Register to attend at Boston.DeviceTalks.com.

DeviceTalks listeners can find our first interview with the Highridge team here. https://www.devicetalks.com/hear-highridge-medicals-plans-to-scale-the-spine-market-a-preview-of-the-medtechvision-conference/

MassDevice Editor Chris Newmarker returns with the Newmarker’s Newsmakers sharing stories about Stereotaxis, the FDA, Philips, Zimmer Biomet, and Stryker.

Thanks for listening to this episode of the DeviceTalks Weekly Podcast.

Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.

Highridge Medical leaders say the spunout startup is ready to battle for spine market supremacy

In 2024, only months before the world lost Dr. Nick Hopkins, Host John Murray, sat down with Dr. Hopkins to discuss his innovative treatments in stroke care, the necessity of collaboration and partnerships to advance research and clinical care, and the importance of mentorship and training the next generation of neurosurgeons.
 
In this special memorial episode, we hear Dr. Hopkins reflect on “not doing everything by the book, but looking around to ask: is there a better way than what’s in the book?” He shares his philosophy on embracing and learning from mistakes that have fueled advancements in neurovascular methodologies and inspired a culture of openness in the medical community. 
 
A champion of mentorship, Dr. Hopkins has acted as a guiding force for numerous professionals, shaping the future of neurovascular surgery. The episode also delves into the ethical and moral compass that underlies Dr. Hopkins’ work, reaffirming the profound humanity that anchors his approach to both his profession and personal life.
 
To honor the depth of Dr. Hopkins’ legacy, we hear directly from many of his mentees and fellows, including Dr. Adnan Siddiqui, Dr. Ricardo Hanel, Dr. Chuck Kerber, Dr. J. Mocco, Dr. Qureshi, Dr. Raphael Rodriguez, Dr. Demetrius Lopes, and Dr. Ajay Wakhlo on the personal and professional impact he has had on their lives and careers.

Thank you to Zeus for sponsoring this episode of Neuro Innovation Talks. To learn more about how Zeus supports medical device companies, visit: www.zeusinc.com.

Special thanks to Dr. Hopkins’s mentees and fellows who shared their stories and to the following for their support in the development of this podcast: Joanna Colangelo, Mark Dickinson, Whitney Garrett, Tracy Murray, SYK, and Dr. Elad Levy.

Tune in and subscribe to the DeviceTalks Podcast Network wherever you get your podcasts and follow youtube.com/@DeviceTalks to never miss an episode.

Thank you for supporting the Neuro Innovation Talks podcast!

Special Memorial Episode: John Murray and Dr Nick Hopkins Discuss Multidisciplinary Neuro Innovation

In this episode of the DeviceTalks Weekly Podcast, Host Tom Salemi talks with Dr. Maria Artunduaga, the founder and CEO of Samay, a startup that’s using acoustic energy to get a clearer picture of the lung’s performance. Family tragedy and professional frustration set Dr. Artunduaga on a course that won MedTech Innovator’s Grand Prize. She has the giant check to prove it.

This episode was sponsored by DeviceTalks Boston. You can register at Boston.DeviceTalks.com.

Rachel Robinson, COO of MassMEDIC, joins us on the Newmarker’s Newsmakers. Before we hit the news of the week, Robinson gave a preview of the upcoming MassMEDIC’s Symposium & Gala on March 6.

Go to MassMEDIC.com for more information.

MassDevice Executive Editor Chris Newmaker then delivers news on - Boston Scientific, ResMed, Globus Medical, BD and Baxter. Hilarity ensues.

Thanks for listening to this episode of the DeviceTalks Weekly Podcast.

Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.

How Samay’s CEO came up with the `sound’ idea for a device to battle COPD, win MedTech Innovator

In this episode of the DeviceTalks Weekly Podcast, Meghan Scanlon, SVP and president of urology at Boston Scientific, updates us on the integration of its powerhouse neurostim acquisition – Axonics. Scanlon also offers great insights on what makes the urology business such a powerful specialty for physicians and medical device executives.

Go here to listen to Scanlon’s first visit with DeviceTalks Weekly. https://www.devicetalks.com/boston-scientific-and-zenflow-are-bringing-critical-new-tools-to-help-urologists-treat-patients/

DeviceTalks Managing Editor Kayleen Brown sits down with Kevin Dempsey, senior director of business development at Tecan, about the opportunities in neuromodulation. Tecan is the sponsor of this episode. To learn more about Tecan visit, https://partnering.tecan.com/

MassDevice Editor Chris Newmarker brings a basket of Newmarker’s Newsmakers including Inspire Medical, Kestra Medical, MGB Layoffs, Medtronic and Johnson & Johnson.

Thanks for listening to the DeviceTalks Weekly Podcast.

Subscribe to the DeviceTalks Podcast Network so you don’t miss an episode.

Boston Scientific’s Scanlon shares secrets to good integration, power of compassion for patients

In this episode of the DeviceTalks Weekly Podcast, MassDevice Editor Chris Newmarker sits down with Wayne Paterson, CEO of Anteris Technologies, a unique start-up that’s approaching the complicated and competitive TAVR market.

Chris Newsmaker and Host Tom Salemi also discuss this week’s Newmarker’s Newsmakers including Medtronic, Boston Scientific, Johnson & Johnson MedTech, NeuroPace and the FDA.

This episode was sponsored by DeviceTalks Minnesota. Register to attend the June 11 event at Minnesota.DeviceTalks.com.

Thanks for listening to the DeviceTalks Weekly Podcast.

Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.

How an artful pivot and IPO is positioning Anteris Technologies to take on the red hot TAVR space

In this episode of the DeviceTalks Weekly Podcast, it’s a DeviceTalks Team Up. Editorial Director Tom Salemi and Managing Editor Kayleen Brown interview Doug Evans, CEO and President of Lungpacer Medical. Evans shares the tragic reason he vowed to start a company that would help wean patients off ventilators. We’ll hear his success story in the podcast, but join us at DeviceTalks Boston to hear the story behind the AeroPace technologies as Evans will be joined by Lungpacer COO Viral Thakkar and Mike Longo, vice president of product development.

Register to attend DeviceTalks Boston at Boston.DeviceTalks.com. If you missed our early bird rate use the code mentioned in the podcast on March 1 and 2.

Before the DeepDive conversation, we’ll have Mass Device Honcho Chris Newmarker’s Newsmakers - Medtronic, Solventum, FDA layoffs, Boston Scientific, and Teleflex.  

Jim Hammerand, managing editor of Medical Design & Outsourcing, opens with an overview of the magazine’s current Min-Vasive issue. You can find all the articles mentioned at medicaldesignandoutsourcing.com.

Thanks for listening to this episode of the DeviceTalks Weekly Podcast.

Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.

Hear Part 1 of Lungpacer Medical’s AeroPace Story; Be part of the conclusion at DeviceTalks Boston

In the kickoff episode of Season 2 of Ortho Innovation Talks, Louie Vogt, Group President of Reconstructive at Enovis, takes us inside the company’s strategic growth in orthopedics. Vogt shares how Enovis has transformed into a major player in the reconstructive space through key acquisitions and bold bets on innovative implant designs.

He discusses the evolution of knee implants, highlighting Enovis’ pioneering work with kinematically driven bearings and the dual pivot knee concept. Vogt also touches on the growing role of robotics and enabling technologies in orthopedic surgery, emphasizing how these advancements are changing the surgeon experience and patient outcomes.

Beyond knees, Vogt explores Enovis’ expansion into foot and ankle reconstruction—a rapidly growing market—and how the company is leveraging M&A and innovation to carve out a competitive edge. As Enovis looks ahead to 2025, Vogt teases major product launches in shoulders, hips, and extremities, signaling another big year for the company.

This conversation comes to you courtesy of our sponsor, Paragon Medical. To learn more about how Paragon Medical can help you bring your device to market faster, visit them at www.paragonmedical.com.

Tune in and subscribe to DeviceTalks on all major podcast channels and follow youtube.com/@DeviceTalks to ensure you never miss an episode.

WATCH and LISTEN below, thank you for supporting Ortho Innovation Talks!

Enovis’ Vogt on driving recon growth past $1B w/ M&A, knee breakthroughs and foot & ankle expansion

In this week’s episode of the DeviceTalks Weekly Podcast, MassDevice Editor Chris Newmarker talks with SynCardia CEO Patrick Schnegelsberg and COO Matthew Schuster. Twenty years after FDA approval, SynCardia is the only company with a commercially available total artificial heart, with more than 2,000 implants. Now they're developing what they think will be a game-changer for the technology: a next-gen artificial heart called the Emperor that will be a fully implantable version, without external drivers.

But before the interview Host Tom Salemi gives a quick recap of the MassMedic Symposium and Gala. Then, Chris Newmarker and Senior Editor Danielle Kirsh unpack MassDevice’s new report on surgical robotic companies.

You can download the report for free here. https://www.massdevice.com/gated/massdevices-surgical-robotics-special-report-2025/

Thanks for listening to the DeviceTalks Weekly Podcast.

Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.

Will SynCardia's Emperor be capable of boldly going where no artificial heart has gone before?

In this episode of the DeviceTalks Weekly Podcast, Host Tom Salemi interviews Todd Langevin, president of BIOTRONIK Neuro, a familiar name in medical devices with a new approach to alleviating pain through spinal cord stimulation. Langevin, who has spent his career in neuro devices, gives his assessment of the field today, explaining how it’s exceeded his early expectations.

Just before that Tom talks with Joe Mullings of The Mullings Group and Surgical Robotics Expert Steve Bell about the state of the surgical robotics industry. The trio will talk about current leaders, emerging powers, and how a shift toward cardiac surgeons could change the playing field completely.

But to start, MassDevice Editor Chris Newmarker joins Tom for the Newmarker’s Newsmakers, the leading stories from the pages of MassDevice. This week’s newsmakers include Tariffs, Medtronic, Surgical Robotics, Stryker, and BCI company Paradromics.

Thank you for listening to this episode of the DeviceTalks Weekly Podcast.

Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.

BIOTRONIK Neuro’s Langevin talks power of connected spinal stim; What’s Next in Surgical Robotics

In this episode of the DeviceTalks Weekly podcast, Host Tom Salemi interviews Alan Lotvin, MD, the CEO and co-founder of Sequel Med Tech, a small company promoting another BIG idea from prolific inventor Dean Kamen. Lotvin, who was formerly a senior executive at CVS/Caremark and PBMs, explains how Twiist, the automated insulin delivery system, could be a game-changer for people with diabetes.

Before the interview, we’ll hear from Ivan Tornos, the CEO and president of Zimmer Biomet. Tornos, who is the opening keynote interview guest at DeviceTalks Boston on April 30 at the Boston Convention & Exhibition Center talks with Salemi and Joe Mullings about the the changes at Zimmer Biomet and in orthopedics.

Register to see Tornos live at Boston.DeviceTalks.com. Use the code mentioned in the podcast to save 25%.

Thanks for listening to the DeviceTalks Weekly Podcast.

Subscribe to the DeviceTalks Podcast Network so you don’t miss a future episode.

Lotvin on why this Sequel AID is better than the original; ZB’s Tornos highlights new tech, ASCs

The DeviceTalks Podcast Network delivers news, insights and commentary from MedTech industry leaders, primarily from the largest OEMs in healthcare. Our podcasts will inspire MedTech professionals to create better MedTech devices and companies.

Explore the DeviceTalks Podcast Network, home to more than 11 podcasts:

• DeviceTalks Weekly
• AbbottTalks
• Boston Scientific Talks
• DeviceTalks AI
• IntuitiveTalks
• MedtechWOMEN Talks
• MedtronicTalks
• Neuro Innovation Talks: J&J MedTech Neuro
• Structural Heart Talks: Edwards Lifesciences
• Ortho Innovation Talks: Zimmer Biomet
• StrykerTalks

WATCH our video podcasts on www.youtube.com/@DeviceTalks

Connect with the hosts:
Tom Salemi, Editorial Director, DeviceTalks https://www.linkedin.com/in/tom-salemi-7118948/
Kayleen Brown, Managing Editor, DeviceTalks https://www.linkedin.com/in/kayleenbrown/

Learn more about DeviceTalks - Podcasts • Conferences • Webinars - www.devicetalks.com

DeviceTalks

Popular tracks